Mariani Mariagabriella, Colombo Federico, Assennato Sonny M, Frugoni Cecilia, Cattaneo Alessandra, Trombetta Elena, Rebulla Paolo, Porretti Laura
Flow Cytometry Service, Laboratory of Clinical Chemistry and Microbiology, IRCCS "Ca' Granda" Foundation, Maggiore Hospital Policlinico, Milan, Italy.
Blood Transfus. 2014 Jul;12(3):416-20. doi: 10.2450/2014.0198-13. Epub 2014 Mar 19.
Accurate estimation of haematopoietic stem cell (HSC) counts by flow cytometry may be difficult in laboratories in which sophisticated equipment and staff with specific expertise are not available. Affordable flow cytometers that can perform basic functions may help to overcome these difficulties. In this study we compared HSC and leucocyte counts determined by volumetric and bead-based protocols performed with the small, low-cost Accuri(®) C6, with those obtained with two gold-standard instruments, the four-colour FACSCalibur(®) and the eight-colour FACSCantoII(®), our reference flow cytometers.
With the three cytometers we tested, in parallel, 111 consecutive samples from cord blood, peripheral blood from patients with myelofibrosis and myeloproliferative syndromes, fresh and thawed HSC collected by apheresis and bone marrow products. The findings were compared with one-way ANOVA, Bland-Altman analysis and linear regression.
The results of HSC and leucocyte enumeration by the three devices were strongly correlated (r(2)>0.99; p<0.0001). ANOVA performed on different subgroups of samples did not reveal significant differences between HSC count determined by the C6 bead-based and reference flow cytometers in any of the subgroups. Regarding the C6 volumetric protocol, a statistically significant difference was observed only in the cord blood subgroup. Time for instrument set-up, calibration and analysis was slightly longer with Accuri(®) C6 (40 min) than with FACSCantoII(®) (30 min).
Accuri(®) C6 is a reliable instrument for HSC enumeration in fresh samples, using both volumetric and bead-based approaches, although the volumetric protocol on cord blood samples needs to be improved. The Accuri(®) C6 is easy to use, does not require profound knowledge of flow cytometry and could be employed in an urgent setting. Its performance may be improved by more efficient calibration and shorter analysis time.
对于那些没有精密设备以及缺乏专业技术人员的实验室而言,通过流式细胞术准确估算造血干细胞(HSC)数量可能存在困难。具备基本功能的经济型流式细胞仪或许有助于克服这些难题。在本研究中,我们将使用小型、低成本的Accuri(®) C6通过体积法和基于微珠的方案测定的HSC和白细胞数量,与使用两台金标准仪器(四色FACSCalibur(®)和八色FACSCantoII(®),即我们的参考流式细胞仪)所获得的结果进行了比较。
我们使用这三台细胞仪,对来自脐带血、骨髓纤维化和骨髓增殖综合征患者的外周血、通过单采术采集的新鲜及解冻的HSC以及骨髓制品的111份连续样本进行了平行检测。通过单因素方差分析、布兰德-奥特曼分析和线性回归对结果进行了比较。
三种仪器对HSC和白细胞计数的结果高度相关(r(2)>0.99;p<0.0001)。对不同样本亚组进行的方差分析未显示基于微珠的C6流式细胞仪与参考流式细胞仪在任何亚组中测定的HSC数量存在显著差异。对于C6体积法方案,仅在脐带血亚组中观察到统计学上的显著差异。Accuri(®) C6(40分钟)的仪器设置、校准和分析时间比FACSCantoII(®)(30分钟)略长。
Accuri(®) C6是一种可靠的仪器,可使用体积法和基于微珠的方法对新鲜样本中的HSC进行计数,尽管脐带血样本的体积法方案有待改进。Accuri(®) C6易于使用,不需要对流式细胞术有深入了解,可用于紧急情况。通过更有效的校准和更短的分析时间,其性能可能会得到改善。